Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes
Nicola Baker, Lucy Glover, Jane C. Munday, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 27, pp. 10996-11001
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

The animal trypanosomiases and their chemotherapy: a review
Federica Giordani, Liam J. Morrison, T.G. Rowan, et al.
Parasitology (2016) Vol. 143, Iss. 14, pp. 1862-1889
Open Access | Times Cited: 392
Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story
Nicola Baker, Harry P. de Koning, Pascal Mäser, et al.
Trends in Parasitology (2013) Vol. 29, Iss. 3, pp. 110-118
Open Access | Times Cited: 233
An Overview of Drug Resistance in Protozoal Diseases
Rita Capela, Rui Moreira, Francisca Lopes
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5748-5748
Open Access | Times Cited: 158
Anti-trypanosomatid drug discovery: progress and challenges
Manu De Rycker, Susan Wyllie, David Horn, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 1, pp. 35-50
Open Access | Times Cited: 126
Arsenic in medicine: past, present and future
Ngozi P. Paul, Adriana E. Galván, Kunie Yoshinaga-Sakurai, et al.
BioMetals (2022) Vol. 36, Iss. 2, pp. 283-301
Open Access | Times Cited: 72
Transforming the chemotherapy of human African trypanosomiasis
Michael P. Barrett
Clinical Microbiology Reviews (2025)
Closed Access | Times Cited: 2
Aquaglyceroporins: Generalized metalloid channels
Rita Mukhopadhyay, Hiranmoy Bhattacharjee, Barry P. Rosen
Biochimica et Biophysica Acta (BBA) - General Subjects (2013) Vol. 1840, Iss. 5, pp. 1583-1591
Open Access | Times Cited: 181
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
Hideo Imamura, Tim Downing, Frederik Van den Broeck, et al.
eLife (2016) Vol. 5
Open Access | Times Cited: 164
The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so
Douglas B. Kell, Paul D. Dobson, Elizabeth Bilsland, et al.
Drug Discovery Today (2012) Vol. 18, Iss. 5-6, pp. 218-239
Closed Access | Times Cited: 147
Drug resistance in eukaryotic microorganisms
Alan H. Fairlamb, Neil A. R. Gow, Keith R. Matthews, et al.
Nature Microbiology (2016) Vol. 1, Iss. 7
Open Access | Times Cited: 145
New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story
Emily A. Dickie, Federica Giordani, Matthew K. Gould, et al.
Tropical Medicine and Infectious Disease (2020) Vol. 5, Iss. 1, pp. 29-29
Open Access | Times Cited: 117
Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs
Jane C. Munday, Anthonius A. Eze, Nicola Baker, et al.
Journal of Antimicrobial Chemotherapy (2013) Vol. 69, Iss. 3, pp. 651-663
Open Access | Times Cited: 115
The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History
Harry P. de Koning
Tropical Medicine and Infectious Disease (2020) Vol. 5, Iss. 1, pp. 14-14
Open Access | Times Cited: 111
Melarsoprol Resistance in African Trypanosomiasis
Alan H. Fairlamb, David Horn
Trends in Parasitology (2018) Vol. 34, Iss. 6, pp. 481-492
Open Access | Times Cited: 109
Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies
Marzuq A. Ungogo, Harry P. de Koning
International Journal for Parasitology Drugs and Drug Resistance (2024) Vol. 25, pp. 100533-100533
Open Access | Times Cited: 13
Minor groove binders as anti-infective agents
Michael P. Barrett, C. G. Gemmell, Colin J. Suckling
Pharmacology & Therapeutics (2013) Vol. 139, Iss. 1, pp. 12-23
Closed Access | Times Cited: 93
Aquaporin 2 Mutations in Trypanosoma brucei gambiense Field Isolates Correlate with Decreased Susceptibility to Pentamidine and Melarsoprol
Fabrice E. Graf, Philipp Ludin, Tanja Wenzler, et al.
PLoS neglected tropical diseases (2013) Vol. 7, Iss. 10, pp. e2475-e2475
Open Access | Times Cited: 89
Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei
Jane C. Munday, Luca Settimo, Harry P. de Koning
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 78
Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis
Juan D. Unciti‐Broceta, José L. Arias, José Maceira, et al.
PLoS Pathogens (2015) Vol. 11, Iss. 6, pp. e1004942-e1004942
Open Access | Times Cited: 75
Intrachromosomal Amplification, Locus Deletion and Point Mutation in the Aquaglyceroporin AQP1 Gene in Antimony Resistant Leishmania (Viannia) guyanensis
Rubens Lima do Monte‐Neto, Marie-Claude N. Laffitte, Philippe Leprohon, et al.
PLoS neglected tropical diseases (2015) Vol. 9, Iss. 2, pp. e0003476-e0003476
Open Access | Times Cited: 70
Inducible high-efficiency CRISPR-Cas9-targeted gene editing and precision base editing in African trypanosomes
Eva Rico, Laura Jeacock, Julie Kovářová, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 65
The Chemical Characterization of Nigerian Propolis samples and Their Activity Against Trypanosoma brucei
Ruwida M. K. Omar, John O. Igoli, Tong Zhang, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 63
Targeting the nucleotide metabolism of Trypanosoma brucei and other trypanosomatids
Anders Hofer
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 3
Open Access | Times Cited: 21
Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies
Miebaka Jamabo, Maduma Ernst Mahlalela, Adrienne L. Edkins, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12529-12529
Open Access | Times Cited: 17
Cyclic AMP Effectors in African Trypanosomes Revealed by Genome-Scale RNA Interference Library Screening for Resistance to the Phosphodiesterase Inhibitor CpdA
Matthew K. Gould, Sabine Bachmaier, Juma A. M. Ali, et al.
Antimicrobial Agents and Chemotherapy (2013) Vol. 57, Iss. 10, pp. 4882-4893
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top